VIVIANCE
Viviance is a web-based platform that provides its users with educational services. It was founded in 1996 and is headquartered in Saint Gallen, Switzerland.
VIVIANCE
Industry:
EdTech Education Web Development
Founded:
1996-01-01
Address:
Saint Gallen, Sankt Gallen, Switzerland
Country:
Switzerland
Website Url:
http://www.viviance.com
Total Employee:
101+
Status:
Closed
Contact:
41 71 2220010
Technology used in webpage:
SPF Google Font API Amazon AWS Global Accelerator OpenResty GoDaddy SSL Namefind
Similar Organizations
Stiefel Eurocart
Stiefel Eurocart is an educational services company.
Umius
Umius is a Russian-based educational consultant company.
Vakademi
Vakademi is an education service-based company.
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2000-05-25 | Informania | Informania acquired by Viviance | N/A |
Investors List
3i Group
3i Group investment in Series B - Viviance
Private Equity Holding
Private Equity Holding investment in Series B - Viviance
Official Site Inspections
http://www.viviance.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Viviance"
About | Changing Kidney Care Forever | Vivance
Vivance is a patient-centric medical technology company with a mission to enhance the lives of people with kidney disease and their caregivers by providing solutions to deliver better …See details»
Viviance - Crunchbase Company Profile & Funding
Viviance is a web-based platform that provides its users with educational services. It was founded in 1996 and is headquartered in Saint Gallen, Switzerland. Lists Featuring This CompanySee details»
AWAK is now Vivance! | Changing Kidney Care Forever | Vivance
Oct 9, 2024 · AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding to Vivance. The name, derived from ‘viva’ and ‘advance’, embodies vitality and …See details»
Viviance Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Viviance. Use the PitchBook Platform to explore the full profile.See details»
Viviance - Funding, Financials, Valuation & Investors - Crunchbase
Mar 15, 2000 · Viviance is funded by 2 investors. 3i Group and Private Equity Holding are the most recent investors. Which investors participated in the most funding rounds? Viviance has …See details»
Products | Changing Kidney Care Forever | Vivance
A novel automated peritoneal dialysis (APD) system with breakthrough features designed to enhance patient experience, reduce treatment burden and optimize therapy outcomes.See details»
Bisanz Organization - Changing Lives
Contact us today to see if you have what it takes for a successful career in sales and management with Bisanz Agencies and AIL.See details»
Visiance | Cabinet de gestion de patrimoine
Découvrez notre équipe de spécialistes qui saura vous accompagner dans vos projets. Visiance est un cabinet de gestion de patrimoine composé de spécialistes. Nous sommes basés à Bourg-de-Péage (siège), Voiron et Lyon.See details»
Lisdexamfetamine - Wikipedia
Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge …See details»
ADHD Sufferers—Pay Attention: Here's How Vyvanse Works
Sep 23, 2016 · Vyvanse is the quintessential example of a "pro-drug"—an inactive substance that becomes active only after it is absorbed and then metabolized in the body to give the parent …See details»
Adderall vs. Vyvanse: What’s the difference for ADHD? - Healthline
Oct 1, 2021 · Vyvanse and Adderall are both approved to treat ADHD in people ages 6 years and older. In fact, they’re both included in the group of drugs used as first-line treatments for ADHD …See details»
Vyvanse ADHD Medication: Dosage, Side Effects And More - Forbes
Jan 23, 2024 · Vyvanse is Food and Drug Administration (FDA) approved to treat ADHD in adults as well as in children aged 6 and older. Vyvanse is also approved to treat moderate to severe …See details»
Kidney Disease | Changing Kidney Care Forever | Vivance
Kidney or Renal disease refers to temporary or permanent damage to the kidneys that result in loss of normal kidney function. Renal failure can be a progressive disease or a temporary one …See details»
Lisdexamfetamine (Vyvanse) - Uses, Side Effects, and More - WebMD
Aug 14, 2024 · Lisdexamfetamine is part of a group of medicines called stimulants. If you have attention deficit hyperactivity disorder (ADHD), this medicine can help increase attention and …See details»
Vyvanse Uses, Dosage, Side Effects & Warnings - Drugs.com
Dec 25, 2023 · Vyvanse is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Vyvanse is FDA-approved to …See details»
Organisation vs. Organization: What’s the Difference?
Organisation is an alternative spelling of the same word. It means the same thing and can be used in all the same contexts. The only difference is that organization is the sole spelling used …See details»
Vyvanse: Uses, Taking, Side Effects, Warnings - Medicine.com
Jan 24, 2020 · Vyvanse is a central nervous system stimulant prescription medicine used to treat: Attention-Deficit/Hyperactivity Disorder (ADHD). Vyvanse may help increase attention and …See details»
Vyvanse Side Effects, Uses, Dosages, Interactions: ADHD Medication
Vyvanse (Generic Name: lisdexamfetamine) is a once-daily, timed-release stimulant ADHD medication used to treat attention deficit hyperactivity disorder (ADHD or ADD) in children …See details»
[Product Monograph Template - Standard]
VYVANSE is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational/vocational, social) for patients with this syndrome. …See details»
Lisdexamfetamine Dimesylate (Vyvanse), A Prodrug Stimulant for ...
Results of the National Comorbidity Survey Replication (NCSR), the first definitive epidemiologic study of ADHD, estimated the prevalence of ADHD to be 4.4% among adults in the U.S., but …See details»